<DOC>
	<DOCNO>NCT02105272</DOCNO>
	<brief_summary>The purpose study determine efficacy safety OPC-1085EL ophthalmic solution comparison latanoprost ophthalmic solution subject insufficiently responsive latanoprost ophthalmic solution .</brief_summary>
	<brief_title>Efficacy Safety Study OPC-1085EL Ophthalmic Solution Subjects With Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Carteolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Subjects diagnosis bilateral primary openangle glaucoma ocular hypertension Subjects ocular condition define protocol</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>